Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis

DOI Web Site Web Site 1 Citations
  • Noemi Rodlan
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Aránzazu Chamorro‐Jorganes
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Elisa Araldi
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Amarylis C. Wanschel
    Departments of MedicineLeon H. Charney Division of Cardiology, and Cell BiologyNew York University School of MedicineNew YorkNew YorkUSA
  • Binod Aryal
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Juan F. Aranda
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Leigh Goedeke
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Alessandro G. Salerno
    Departments of MedicineLeon H. Charney Division of Cardiology, and Cell BiologyNew York University School of MedicineNew YorkNew YorkUSA
  • Cristina M. Ramírez
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • William C. Sessa
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Yajaira Suárez
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
  • Carlos Fernández‐Hernando
    Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA

Journal

Citations (1)*help

See more

Report a problem

Back to top